From: An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study
Metric
Intervention 3HP n (proportion) [CI*]
Standard 3HR n (proportion) [CI*]
Allocated to group
27
25
Received at least 90% of prescribed doses
21 (0.78) [0.58–0.91]
19 (0.76) [0.55–0.91]